Hillsdale Investment Management »

Neurocrine Biosciences shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $657k 4.8k 137.92
2023-12-31 $634k 4.8k 131.76
2023-06-30 $409k 4.3k 94.30
2023-03-31 $439k 4.3k 101.22
2022-12-31 $471k 3.9k 119.44
2022-09-30 $15k 140 107.14
2022-06-30 $14k 140 100.00
2013-09-30 $44k 3.9k 11.28